This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Idexx Laboratories, Inc.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Greg Francoeur: Innovator in Canine Allergy Treatment
Introduction
Greg Francoeur is a notable inventor based in North Yarmouth, ME (US). He has made significant contributions to the field of veterinary medicine, particularly in the treatment of canine allergies. His innovative work has led to the development of a unique patent that addresses a common issue faced by pet owners.
Latest Patents
Greg Francoeur holds a patent for "Specific binding proteins for treating canine allergy." This patent discloses binding proteins that specifically bind to an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair. Other binding proteins included in the invention specifically bind to isolated and purified peptides with specific sequences, such as cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine (SEQ ID NO:6) or cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine (SEQ ID NO:9). This innovative approach has the potential to improve the quality of life for many dogs suffering from allergies.
Career Highlights
Greg is currently employed at IDEXX Laboratories, Inc., a company renowned for its commitment to advancing veterinary diagnostics and healthcare. His work at IDEXX has allowed him to focus on developing solutions that enhance the well-being of animals. With a patent portfolio that includes one significant patent, Greg has established himself as a key player in the field of veterinary innovation.
Collaborations
Some of Greg's coworkers include Robert L. Lawton and Brion Mermer. Their collaboration within IDEXX Laboratories, Inc. fosters an environment of innovation and shared expertise, contributing to the advancement of veterinary medicine.
Conclusion
Greg Francoeur's contributions to the field of canine allergy treatment exemplify the impact of innovation in veterinary medicine. His patent for specific binding proteins showcases his dedication to improving animal health. Through his work at IDEXX Laboratories, Inc., Greg continues to make strides in enhancing the lives of pets and their owners.